Roadblocks to translational advances on metastasis research

Thomas Brabletz1, David Lyden, Patricia S Steeg

  • 11] Department of General and Visceral Surgery, Comprehensive Cancer Center and BIOSS Centre for Biological Signalling Studies, University of Freiburg Medical Center, Freiburg, Germany. [2].

Nature Medicine
|September 10, 2013
PubMed

Insights

Despite advances in understanding cancer's molecular basis, preventing cancer metastasis remains a significant challenge. Experts convened to identify key hurdles and develop strategies for clinical translation in metastasis research.

Area of Science:

  • Oncology
  • Translational Medicine
  • Cancer Metastasis Research

Background:

  • Significant progress in understanding cancer's molecular and genetic basis.
  • Development of effective drugs to prevent cancer cell dissemination and metastasis remains a challenge.

Purpose of the Study:

  • To address critical translational issues in cancer metastasis.
  • To identify major hurdles in metastasis research and clinical application.
  • To establish a framework for future clinical and translational strategies.

Main Methods:

  • A 2012 meeting convened experts in metastasis research.
  • Collaboration between the Volkswagen Foundation and Nature Medicine.
  • Discussion focused on identifying key challenges and potential solutions.

Main Results:

  • Identified significant hurdles in preventing cancer metastasis.
  • Highlighted the need for improved clinical and translational strategies.
  • Established a collaborative framework for future research.

Conclusions:

  • Addressing metastasis requires a concerted effort from researchers, physicians, and funding bodies.
  • Translational strategies are crucial for combating cancer spread.
  • Continued focus on molecular and genetic underpinnings is essential for therapeutic advances.